Consistent with the bad prognosis of MMP14 and PKM2, pancreatic cancer patients with higher expression of MMP14 or PKM2 had more unfavorable clinical overall survival (Figure 9B). This evidence concerns the gene MMP14 and familial pancreatic carcinoma.